Frequency of cardiac death in children with idiopathic dilated cardiomyopathy

The American Journal of Cardiology
V Vivian DimasNaomi J Kertesz

Abstract

The prognosis in children with idiopathic dilated cardiomyopathy (IDC) is guarded, with the 5-year mortality rate ranging from 14% to 50%, owing to sudden cardiac death (SCD) or pump failure. The risk factors for SCD in adults with IDC include asymptomatic nonsustained ventricular tachycardia and poor left ventricular function. It is unclear whether these findings can be extrapolated to the pediatric population. A retrospective review of all patients with the diagnosis of IDC seen at a single institution from 1990 to 2004 was performed. A total of 85 patients (46 males), with a median age of 3.8 years (0 days to 17.3 years) were studied. The mean left ventricular ejection fraction was 25 +/- 12% (median 23%, range 45% to 45%) at presentation. The following arrhythmias occurred at presentation or during the initial hospitalization: nonsustained ventricular tachycardia in 6, sustained ventricular tachycardia or fibrillation in 1, supraventricular arrhythmias in 6, and both atrial and ventricular arrhythmias in 1. During a subsequent hospitalization or outpatient follow-up, 7 patients had the following arrhythmias: supraventricular arrhythmias in 2, nonsustained ventricular tachycardia in 4, and both atrial and ventricular arrhyth...Continue Reading

References

Jul 1, 1991·Journal of the American College of Cardiology·R A FriedmanA Garson
Aug 10, 2000·Journal of the American College of Cardiology·P A CarsonM Packer
May 21, 2004·The New England Journal of Medicine·Alan KadishUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators

❮ Previous
Next ❯

Citations

Jun 18, 2014·The Journal of Experimental Medicine·Lei WuDaniela Ciháková
May 15, 2013·Current Cardiology Reports·Sarah M SelemJoshua M Hare
Aug 13, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Duy T DaoAnne M Dubin
Aug 21, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Melanie D Everitt
Mar 8, 2016·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Sharon ChenScott R Ceresnak
May 30, 2015·Journal of the American College of Cardiology·Tara BharuchaUNKNOWN NACCS (National Australian Childhood Cardiomyopathy Study) Investigators
Sep 1, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Silvia G PrioriUNKNOWN Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Eur
Feb 4, 2012·Journal of the American College of Cardiology·Elfriede PahlUNKNOWN Pediatric Cardiomyopathy Registry Investigators
Jun 29, 2018·European Journal of Immunology·Guobao ChenDaniela Čiháková
May 15, 2018·Frontiers in Immunology·Lee A Meier, Bryce A Binstadt
Jun 13, 2019·European Journal of Pediatrics·Muhammad Bassem Jammal AddinLindsey Hunter
Mar 5, 2016·Pacing and Clinical Electrophysiology : PACE·Richard J CzosekDavid S Spar
Jul 22, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Kathleen C WoulfeBrian L Stauffer
Oct 3, 2018·Pediatrics·Sujatha BuddheAaron K Olson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Edward K RheeDavid C Naftel
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Duy T DaoAnne M Dubin
Journal of the American College of Cardiology
Richard A FriedmanA Garson
The New England Journal of Medicine
Alan H KadishDefibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
© 2022 Meta ULC. All rights reserved